Home › Neuroblastoma
Pag-aaral pangklinika para sa Neuroblastoma na nagre-recruit sa U.S.
47 pag-aaral para sa Neuroblastoma ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Boston, MA13 pag-aaral
- Washington, DC11 pag-aaral
- New York City, NY10 pag-aaral
- St. Louis, MO9 pag-aaral
- Dallas, TX9 pag-aaral
- Philadelphia, PA9 pag-aaral
- Memphis, TN9 pag-aaral
- Birmingham, AL8 pag-aaral
- Hartford, CT8 pag-aaral
- Minneapolis, MN8 pag-aaral
- Aurora, CO8 pag-aaral
- Houston, TX7 pag-aaral
- Orlando, FL7 pag-aaral
- Miami, FL7 pag-aaral
- Los Angeles, CA7 pag-aaral
- San Francisco, CA7 pag-aaral
- Atlanta, GA7 pag-aaral
- Cincinnati, OH7 pag-aaral
- Harrisburg, PA6 pag-aaral
- Portland, OR6 pag-aaral
- Little Rock, AR6 pag-aaral
- Honolulu, HI6 pag-aaral
- Durham, NC6 pag-aaral
- Gainesville, FL6 pag-aaral
- Salt Lake City, UT6 pag-aaral
- Greenburgh, NY6 pag-aaral
- Chicago, IL6 pag-aaral
- Seattle, WA6 pag-aaral
- San Diego, CA5 pag-aaral
- Oakland, CA5 pag-aaral
- Austin, TX5 pag-aaral
- Mountain View, CA5 pag-aaral
- Nashville, TN5 pag-aaral
- Ann Arbor, MI5 pag-aaral
- Columbus, OH5 pag-aaral
- Charlotte, NC4 pag-aaral
- Grand Rapids, MI4 pag-aaral
- Charleston, SC4 pag-aaral
- Louisville, KY4 pag-aaral
- Kansas City, MO4 pag-aaral
Ayos sa estado
- Alabama8 pag-aaral
- Arizona3 pag-aaral
- Arkansas6 pag-aaral
- California14 pag-aaral
- Colorado8 pag-aaral
- Connecticut9 pag-aaral
- District of Columbia6 pag-aaral
- Florida9 pag-aaral
- Georgia9 pag-aaral
- Hawaii6 pag-aaral
- Illinois6 pag-aaral
- Indiana3 pag-aaral
- Iowa3 pag-aaral
- Kentucky5 pag-aaral
- Maryland8 pag-aaral
- Massachusetts13 pag-aaral
- Michigan8 pag-aaral
- Minnesota9 pag-aaral
- Missouri10 pag-aaral
- New Jersey6 pag-aaral
- New York13 pag-aaral
- North Carolina7 pag-aaral
- North Dakota3 pag-aaral
- Ohio8 pag-aaral
- Oregon6 pag-aaral
- Pennsylvania14 pag-aaral
- Rhode Island3 pag-aaral
- South Carolina4 pag-aaral
- South Dakota3 pag-aaral
- Tennessee12 pag-aaral
- Texas15 pag-aaral
- Utah6 pag-aaral
- Virginia3 pag-aaral
- Washington6 pag-aaral
- Wisconsin4 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
4 Weeks · Lahat ng kasarian · Na-update Set 28, 2026 · NCT01109394Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma
Nagre-recruitPhase 1
Edad 3 hanggang 35 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06995872Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Nagre-recruitPhase 3
Hanggang edad 30 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06172296Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
Nagre-recruitObservasyonal na pag-aaral
Edad 4 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT01005654Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Nagre-recruitPhase 1/2
6 Months – 25 Years · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06395103Biomarkers of Resiliency In Childhood Cancer Surgery
Nagre-recruitObservasyonal na pag-aaral
Edad 3 hanggang 25 · Lahat ng kasarian · Na-update Set 14, 2026 · NCT06674811Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Nagre-recruitPhase 2
Hanggang edad 22 · Lahat ng kasarian · Na-update Set 4, 2026 · NCT02559778Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Nagre-recruitPhase 1/2
Hanggang edad 30 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06541262B7-H3.CD28Z.CART in Solid Tumors
Nagre-recruitPhase 1
9 Months – 30 Years · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07358260Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
Nagre-recruitPhase 1/2
Hanggang edad 26 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06465199Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
Nagre-recruitPhase 2
Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06540963International Congenital Central Hypoventilation Syndrome (CCHS) Registry and CCHS SHARE
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Set 3, 2026 · NCT03088020N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma
Nagre-recruitPhase 2
18 Months – 19 Years · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT06528496Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Nagre-recruitPhase 1/2
12 Months – 30 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04851119Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Nagre-recruitPhase 3
365 Days – 30 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT03126916Haploidentical Donor Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Neuroblastoma
Nagre-recruitPhase 2
Edad 1 hanggang 39 · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT07635056Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)
Nagre-recruitPhase 1
Edad 1 hanggang 23 · Lahat ng kasarian · Na-update Ago 13, 2026 · NCT07172958Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Nagre-recruitPhase 2
12 Months – 21 Years · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT05489887A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma
Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
Lahat ng edad · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT04936529SPEARHEAD-3 Pediatric Study
Nagre-recruitPhase 1/2
Edad 2 hanggang 21 · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT05642455A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma
Nagre-recruitPhase 2
Lahat ng edad · Lahat ng kasarian · Na-update Hul 28, 2026 · NCT06057948PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Nagre-recruitPhase 1/2
Edad 1 hanggang 30 · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT06721689NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma
Nagre-recruitPhase 1
Edad 1 hanggang 24 · Lahat ng kasarian · Na-update Hul 21, 2026 · NCT07211737NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
Nagre-recruitPhase 2
Edad 1 hanggang 31 · Lahat ng kasarian · Na-update Hul 20, 2026 · NCT06450041Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
Nagre-recruitPhase 1
Edad 1 hanggang 30 · Lahat ng kasarian · Na-update Hul 14, 2026 · NCT07027748Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.